Scott Anglin
About Scott Anglin
Scott Anglin is a Scientist I at Asklepios BioPharmaceutical, Inc. in the Raleigh-Durham area, where he has worked since 2019. He has a strong background in bio-molecular engineering and expertise in AAV Biology, with previous roles in academia and industry.
Work at Asklepios BioPharmaceutical
Scott Anglin has been employed as Scientist I at Asklepios BioPharmaceutical, Inc. (AskBio) since 2019. He works in the Raleigh-Durham, North Carolina Area, contributing to the company's research and development efforts in gene therapy. His role involves applying his expertise in AAV Biology and bio-molecular engineering to advance therapeutic solutions.
Education and Expertise
Scott Anglin holds a Bachelor's degree in Environmental Biology and a Master's degree in Molecular Biology, both from the University of Southern Mississippi. He also earned an Associate's degree in Art/Art Studies from Pearl River Community College. His educational background supports his expertise in bio-molecular engineering, AAV Biology, nucleic acid and protein purification, and bioinformatics.
Background in Higher Education
Scott Anglin has a strong foundation in academia, having served as a Graduate Teaching Assistant and Graduate Student at the University of Southern Mississippi from 2011 to 2014. He also worked as an Undergraduate Research Assistant at the same institution. His academic roles provided him with significant experience in biological sciences and research methodologies.
Previous Experience in Research and Development
Before joining Asklepios BioPharmaceutical, Scott Anglin worked as a Research Associate 2 at Louisiana State University School of Veterinary Medicine from 2014 to 2016. He also held the position of Lab Manager at Clemson University from 2017 to 2019. These roles contributed to his practical experience in the biotech industry and enhanced his research skills.
Skills in Molecular Biology
Scott Anglin possesses strong skills in molecular biology techniques, including nucleic acid and protein purification. His proficiency in bioinformatics allows him to analyze and interpret complex biological data, making him a valuable asset in research settings focused on gene therapy and related fields.